Umbral Energy Corp.
Umbral Energy Corp.
acquiring assets, unlocking value.
The Company participates, through identification and strategic alliances, for opportunities to increase shareholder value with focus on growth and cash flow.
The Company is currently listed as a junior resource issuer having mineral exploration projects. The Company is considering other activities to increase shareholder value, including non-resource projects.
The Company has a mineral exploration projects in Utah, Nevada and Quebec.
In addition Umbral has an interest in PhyeinMed, who has applied for a license from Health Canada to legally grow and sell medical marijuana. The board of Directors has approved the Company’s plan to enter the medical marijuana business and its general plan to diversify its business into other industry sectors outside of the mining resource sector with a view of creating value for shareholders. The Company confirms that the Acquisition is not a Fundamental Change, as defined in Policy 8 of the Canadian Securities Exchange. However, if the Acquisition results in a Fundamental Change, the approval of the Company’s shareholders is required. There can be no assurance that the Acquisition or any other transactions for the Company’s prospective projects in the medical marijuana industry will be successfully completed.
Ability to Explore, Develop, and Operate.
Umbral Energy Corp. is an exploration and development company with a focus on becoming a low cost supplier for the burgeoning energy industry.
UMBRAL ENERGY samples up to 204 ppm lithium at tule
Valley Lithium Exploration project. Geochemical results of up to 204 PPM Lithium from samples taken on its 100% owned project...
Umbral energy acquires sAN eMIDIO LITHIUM PROPERTy neAR gerlach, nevada
The San Emidio Desert is the name given to the playa extending south from Gerlach. San Emidio is the southern “tongue” of the largest dry lake bed in North America...
Umbral Energy Corp. is a resource exploration company, management will continue to review opportunities to increase shareholder value.
Jag Bal, President & CEO
Umbral Energy Corp.
929 Mainland St.
Vancouver, BC V6B 1S3
Copyright All Rights Reserved © 2016
Documents and information
click on the following link:
Documents filed on SEDAR
ISSUED AND OUTSTANDING 70,898,146
Update on Medical Marijuana Application
Initiation of security clearance process, in Health Canada’s application of becoming a licensed grower under the Marihuana of Medical Purposes Regulations...
industrial hemp application
Umbral is pleased to announce that in partnership with a hemp based Canadian company is proceeding with an investment to finance the application of an industrial hemp licence.
acmpr application update
Umbral is pleased to announce that PhyeinMed Inc. is in communication with Health Canada and its ACMPR (Access to Cannabis for Medical Purposes Regulations) application has been assured that the application is progressing through the application process.
cannabis task force report implication
Umbral with its partner, PhyeinMed Inc. (“PhyeinMed”) is encouraged by the recommendations released by the Canadian government's task force report on marijuana legalization and regulation.
RISKS AND UNCERTAINTIES INHERENT TO THE PROPOSED MEDICAL MARIJUANA BUSINESS
UMBRAL with its partner, PhyeinMed Inc. is issuing this press release as a result of a review by the British Columbia Securities Commission. This clarifying news release is intended to provide further disclosure about the Company’s pursuit of opportunities in the medical marijuana business.
UNAWARE OF ANY MATERIAL CHANGE
Vancouver, B.C., February 10, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) at the request of IIROC, the Company wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.
INCENTIVE STOCK OPTION GRANT
Vancouver, B.C., February 10, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) announces, that it has granted a total of 3,450,000 incentive stock options to directors/officers/employees and/or consultants under the Company’s Stock Option Plan. The options are exercisable at $0.07 per share and will expire February 10, 2022. Following this grant of options, the Company has 6,400,000 stock options outstanding.
UMBRAL’S PARTNER PHYEINMED RECEIVES ACMPR APPROVAL TO COMMENCE STAGE 5
Vancouver, B.C., February 16, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral” or “Company”) is pleased to announce that PhyeinMed Inc. (“PhyeinMed”)has received notification from Health Canada that its ACMPR (Access to Cannabis for Medical Purposes Regulations) application has progressed through to the Review Stage (stage 5 of 7) of the application process.
UMBRAL ASSIGNS INTEREST IN TULE VALLEY, UT AND GERLACH, NV LITHIUM PROJECTS
Vancouver, B.C., February 17, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (“Umbral” or “Company”) is pleased to announce that subject to regulatory acceptance, Umbral has entered into an Assignment Agreement with Equitorial Exploration Corp. for them to acquire 100% interest in the Tule Valley project in Utah and the San Emidio Project in Gerlach, NV.
INCENTIVE STOCK OPTION GRANT
Vancouver, B.C., February 27, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) announces, that it has granted a total of 6,000,000 incentive stock options to directors/officers/employees and/or consultants under the Company’s Stock Option Plan. The options are exercisable at $0.065 per share and will expire February 27, 2022. Following this grant of options, the Company has 6,900,000 stock options outstanding.
Vancouver, B.C., February 21, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) is pleased to announce that it has initiated the purchase of the property located in Falkland, BC. to be used to grow medical cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and its 50% interest in an application submitted by PhyeinMed Inc. (“PhyeinMed”). PhyeinMed is a Stage 5 Review applicant owned 50 % by Umbral.
UMBRAL ACQUIRES ADDITIONAL 25% INTEREST IN PHYEINMED, A HEALTH CANADA ACMPR STAGE 5 REVIEW STAGE APPLICANT
Vancouver, B.C., March 6, 2017 – UMBRAL ENERGY CORP. (CSE: UMB)(OTC: UMBBF) (“Umbral or Company”) is pleased to announce that it has signed a binding Letter of Intent (“LOI”) to acquire an additional 25% interest in PhyeinMed Inc. (“PhyeinMed”), a Health Canada Stage 5 Review Stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). With this purchase, Umbral now holds 75% ownership of PhyeinMed Inc.